USS Investment Management Ltd Sells 57,028 Shares of Agilent Technologies, Inc. $A

USS Investment Management Ltd trimmed its stake in Agilent Technologies, Inc. (NYSE:A) by 50.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 56,851 shares of the medical research company’s stock after selling 57,028 shares during the quarter. USS Investment Management Ltd’s holdings in Agilent Technologies were worth $6,481,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. IFM Investors Pty Ltd increased its position in Agilent Technologies by 7.0% in the 1st quarter. IFM Investors Pty Ltd now owns 56,292 shares of the medical research company’s stock valued at $6,416,000 after buying an additional 3,681 shares in the last quarter. Capricorn Fund Managers Ltd bought a new position in Agilent Technologies in the first quarter worth approximately $8,161,000. Premier Path Wealth Partners LLC grew its stake in Agilent Technologies by 18.4% in the first quarter. Premier Path Wealth Partners LLC now owns 1,882 shares of the medical research company’s stock valued at $215,000 after acquiring an additional 293 shares during the period. Inspire Investing LLC increased its holdings in shares of Agilent Technologies by 7,306.7% during the first quarter. Inspire Investing LLC now owns 1,111 shares of the medical research company’s stock valued at $127,000 after acquiring an additional 1,096 shares in the last quarter. Finally, waypoint wealth counsel increased its holdings in shares of Agilent Technologies by 16.4% during the first quarter. waypoint wealth counsel now owns 2,291 shares of the medical research company’s stock valued at $261,000 after acquiring an additional 323 shares in the last quarter. 87.41% of the stock is owned by institutional investors.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $130.79 on Friday. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The company’s 50 day moving average price is $123.80 and its two-hundred day moving average price is $125.95. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The stock has a market cap of $36.94 billion, a P/E ratio of 26.26, a P/E/G ratio of 2.37 and a beta of 1.25.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. The company had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post 6 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

Analyst Ratings Changes

Several analysts recently issued reports on A shares. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. TD Cowen raised their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and lowered their target price for the stock from $150.00 to $145.00 in a report on Thursday, May 28th. Finally, Piper Sandler initiated coverage on Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target for the company. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $160.88.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.